164 related articles for article (PubMed ID: 30278461)
1. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of prognostic value of
Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
[No Abstract] [Full Text] [Related]
3. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
Jing X; Liang H; Hao C; Yang X; Cui X
Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
6. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
[TBL] [Abstract][Full Text] [Related]
7. Cell division cycle proteinising prognostic biomarker of breast cancer.
Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta-analysis.
Binabaj MM; Bahrami A; Bahreyni A; Shafiee M; Rahmani F; Khazaei M; Soleimanpour S; Ghorbani E; Fiuji H; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
J Cell Biochem; 2018 Nov; 119(11):9583-9590. PubMed ID: 30129051
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of long non-coding RNA MEG3 indicates an unfavorable prognosis in non-small cell lung cancer: Evidence from the GEO database.
Zhang Z; Liu T; Wang K; Qu X; Pang Z; Liu S; Liu Q; Du J
Gene; 2017 Sep; 630():49-58. PubMed ID: 28782577
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
Wang Q; Zhao S; Gan L; Zhuang Z
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells.
Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G
J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer.
Zhang JJ; Guo SH; Jia BQ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5143-5147. PubMed ID: 28051255
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
16. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
